Geographic Atrophy clinical trials at UCSD
1 in progress, 0 open to new patients

• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

  Sorry, not currently recruiting here

  This is a 30-month, Phase III, multicenter, randomized, double-masked, sham-injection controlled study to assess the efficacy and safety of multiple IVT injections of APL-2 in subjects with GA secondary to AMD.

  La Jolla, California and other locations

Last updated: October 1, 2018